Entry Detail



General Information

Database ID:exR0363628
RNA Name:GDI2
RNA Type:mRNA
Chromosome:chr10
Starnd:-
Coordinate:
Start Site(bp):5765223End Site(bp):5842132
External Links:ENSG00000057608



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADH5
chr4
99070978
99088801
-
ABHD17A
chr19
1876810
1885547
-
ADIPOR2
chr12
1688574
1788674
+
ACAA2
chr18
49782164
49813953
-
AC026954.2
chr17
7312661
7319174
-
AC010422.3
chr19
12643831
12648397
-
AC245033.1
chr15
82536788
82573194
-
AC008763.2
chr19
7629796
7643048
+
ADCY6
chr12
48766194
48789037
-
ADO
chr10
62804720
62808479
+
ACTB
chr7
5527148
5563784
-
ADK
chr10
74151202
74709963
+
AC073283.3
chr2
47065941
47176511
-
ACADVL
chr17
7217125
7225266
+
ALDOA
chr16
30064164
30070457
+
AD000671.1
chr19
35745678
35754519
+
ACADM
chr1
75724347
75787575
+
ADCY2
chr5
7396138
7830081
+
ADAMTS19
chr5
129460281
129738683
+
ADAMTS13
chr9
133414358
133459402
+
ACTG1
chr17
81509971
81523847
-
ACSL3
chr2
222860942
222944639
+
AC073508.2
chr17
40627356
40665141
-
AFDN
chr6
167826922
167972023
+
AFG3L2
chr18
12328944
12377227
-
ACOT9
chrX
23701055
23766475
-
ALDH18A1
chr10
95605941
95656711
-
AC000093.1
chr22
19717220
19724772
+
ACSS2
chr20
34872146
34927962
+
ABHD17B
chr9
71862452
71910931
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009446.1
chr8
71675300
71702786
+
AC010542.4
chr16
66549280
66551189
+
AC016876.2
chr17
7581964
7584086
-
AC124068.2
chr15
89335053
89336161
+
AC147067.1
chr4
1574062
1580253
-
AC245033.4
chr15
82533175
82540008
-
AL021707.2
chr22
38667585
38681847
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.